Welcome to our dedicated page for Osterweis Growth & Income Fund news (Ticker: OSTVX), a resource for investors and traders seeking the latest updates and insights on Osterweis Growth & Income Fund stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Osterweis Growth & Income Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Osterweis Growth & Income Fund's position in the market.
Osterweis Capital Management announced the renaming of the Osterweis Strategic Investment Fund to the Osterweis Growth & Income Fund. Along with this, the management fee for both the Osterweis Fund (OSTFX) and the newly named Osterweis Growth & Income Fund (OSTVX) has been reduced to 0.75%. Co-President Catherine Halberstadt emphasized the firm's commitment to active management and downside risk mitigation. Portfolio Manager Larry Cordisco highlighted the fund's strategy of combining equities and fixed income to provide growth and income, particularly appealing for retirees.
